Gross Profit for Incyte (INCY)
According to Incyte's latest reported financial statements, the company's current gross profit (TTM) is $3.76B USD. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
INCY
Currently viewingGross ProfitSwitch metric
TTM (last 4 quarters)
$3.76B
YoY change
+21.7%
5Y CAGR
+13.4%
Peak year (2025)
$4.70B
Cumulative gross profit
$29.51B
Gross Profit history chart for Incyte (INCY) from 1993 to 2025
Gross Profit history table for Incyte (INCY) from 1993 to 2025
| Fiscal year | Period ended | Reported | Gross Profit | YoY |
|---|---|---|---|---|
| 2025 | $4.70B | +21.7% | ||
| 2024 | $3.86B | +14.3% | ||
| 2023 | $3.38B | +7.6% | ||
| 2022 | $3.14B | +12.2% | ||
| 2021 | $2.80B | +11.7% | ||
| 2020 | $2.51B | +24.5% | ||
| 2019 | $2.01B | +14.7% | ||
| 2018 | $1.75B | +23.0% | ||
| 2017 | $1.43B | +42.4% | ||
| 2016 | $1.00B | +42.2% | ||
| 2015 | $704.34M | +50.8% | ||
| 2014 | $467.08M | +43.7% | ||
| 2013 | $325.11M | +21.8% | ||
| 2012 | $266.92M | +295.6% | ||
| 2011 | $67.47M | — | ||
| 2010 | $0 | — | ||
| 2009 | $0 | — | ||
| 2008 | $0 | — | ||
| 2007 | $0 | — | ||
| 2006 | $0 | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | -100.0% | ||
| 2003 | $47.09M | -53.7% | ||
| 2002 | $101.61M | -53.7% | ||
| 2001 | $219.26M | -4.3% | ||
| 2000 | $229.01M | +26.0% | ||
| 1999 | $181.70M | +19.1% | ||
| 1998 | $152.60M | +54.5% | ||
| 1997 | $98.80M | +104.6% | ||
| 1996 | $48.30M | +226.4% | ||
| 1995 | $14.80M | +1245.5% | ||
| 1994 | $1.10M | -133.3% | ||
| 1993 | -$3.30M | — |
Gross Profit values are taken from Incyte's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Incyte (INCY) gross profit totalled $4.70B – grew 21.7% year-over-year.
Over 2020–2025 (5 years), Incyte gross profit expanded at a +13.4% compound annual rate, sustaining 15 straight years of year-over-year growth.
Across the available history, gross profit reached its high of $4.70B in 2025 and its low of -$3.30M in 1993.
Incyte (INCY) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $53.80B.
Incyte Gross Profit by Year
Incyte Gross Profit 2025: $4.70B
Incyte gross profit in 2025 was $4.70B, grew 21.7% from 2024. This figure represents the highest annual value in the available history.
Incyte Gross Profit 2024: $3.86B
Incyte gross profit in 2024 was $3.86B, grew 14.3% from 2023.
Incyte Gross Profit 2023: $3.38B
Incyte gross profit in 2023 was $3.38B, grew 7.6% from 2022.
Incyte Gross Profit 2022: $3.14B
Incyte gross profit in 2022 was $3.14B, grew 12.2% from 2021.
Incyte Gross Profit 2021: $2.80B
Incyte gross profit in 2021 was $2.80B.
See more financial history for Incyte (INCY).
Sector peers — Gross Profit
Companies in the same sector as Incyte, ranked by their latest gross profit.
| Company | Gross Profit | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $250.28B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $82.92B | Healthcare |
| Johnson & Johnson (JNJ) | $68.56B | Healthcare |
| Eli Lilly and Company (LLY) | $54.62B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.98B | Healthcare |
| AstraZeneca PLC (AZN) | $48.11B | Healthcare |
| AbbVie Inc. (ABBV) | $42.96B | Healthcare |
| Amgen Inc. (AMGN) | $26.01B | Healthcare |
Frequently asked questions
What is Incyte's gross profit?
- Latest reported gross profit for Incyte (INCY) is $3.76B (period ending March 31, 2026).
How has Incyte gross profit changed year-over-year?
- Incyte (INCY) gross profit changed +21.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Incyte gross profit?
- Incyte (INCY) gross profit compound annual growth rate is +13.4% over the most recent 5 years available.
When did Incyte gross profit hit its highest annual value?
- Incyte gross profit reached its highest annual value of $4.70B in 2025.
What was Incyte gross profit in 2024?
- Incyte (INCY) gross profit in 2024 was $3.86B.
What was Incyte gross profit in 2025?
- Incyte (INCY) gross profit in 2025 was $4.70B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
INCY Overview
Company profile, financial tools, and key metrics
INCY Revenue Counter
Earns $163.03 every second. See per minute, hour, and day.
INCY Earnings Counter
Earns $40.80 per second net profit. See per minute, hour, and day.
INCY Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
INCY What If Invested
What if you had invested $1,000? See historical returns from any date.
INCY How It Makes Money
Discover visual breakdown of $5.14B in revenue — where it comes from and where it goes.
INCY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
INCY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
INCY Daily Price Character
Explosive · 48.3% historical win rate (green days). Streaks & record days.
INCY Buybacks
0.10% TTM buyback yield. Shareholder yield & SBC comparison.
INCY Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.